ICD Implantation in Patients With Ischemic Left Ventricular Dysfunction

Area of Science:

• Cardiology
• Electrophysiology
• Preventive Medicine

Background:

• Sudden cardiac death (SCD) accounts for the majority of heart disease-related fatalities.
• Risk stratification in ischemic heart disease aims to identify individuals who could benefit from an implantable defibrillator.
• Left ventricular ejection fraction is the primary clinical metric for selecting patients for primary prevention implantable cardioverter-defibrillator (ICD) therapy.

Purpose of the Study:

• To highlight the limitations of current risk stratification methods for sudden cardiac death.
• To emphasize the need for improved patient selection for implantable cardioverter-defibrillator (ICD) therapy.
• To advocate for further research into more accurate risk assessment tools.

Main Methods:

• Review of current clinical practices in sudden cardiac death risk stratification.
• Analysis of the efficacy of left ventricular ejection fraction in predicting sudden cardiac death.
• Identification of gaps in current risk assessment protocols.

Main Results:

• Many sudden cardiac deaths occur in patients lacking traditional high-risk indicators.
• A significant number of patients receiving implantable cardioverter-defibrillators (ICDs) do not experience device therapy activation.
• Existing risk stratification methods demonstrate suboptimal accuracy.

Conclusions:

• Current methods for selecting patients for implantable cardioverter-defibrillator (ICD) therapy are inadequate.
• There is a critical need to develop and validate novel risk stratification tools.
• Improved patient selection will optimize the use of defibrillator therapy and reduce sudden cardiac death.